Navigation Links
DaVita Abstracts Accepted into American Society of Nephrology Meeting
Date:11/4/2008

Fifteen Abstracts Will Be Featured at ASN

EL SEGUNDO, Calif., Nov. 4 /PRNewswire/ -- DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research(R) (DCR), recently contributed fifteen abstracts to the 41st Annual Meeting & Scientific Exposition of the American Society of Nephrology. These abstracts were developed both internally and through intellectual partnerships with leaders in nephrology.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

DaVita Chief Medical Officer, Allen R. Nissenson, MD, FACP, FASN and Emeritus Professor of Medicine at the David Geffen School of Medicine at UCLA states, "DaVita is committed to improving the lives of patients with kidney disease. Generating new knowledge through research is an important component of meeting this commitment. The Office of the Chief Medical Officer (OCMO) in its Relentless Pursuit of Quality will continue to work closely with DCR and our external academic partners to significantly impact patient outcomes through clinical research."

The American Society of Nephrology (ASN) is organized and operated primarily for scientific and educational purposes, and advocates for the development of national health policies to improve the quality of care for renal patients. Renal Week 2008 is November 4-9 in Philadelphia, PA. DaVita Clinical Research collaborates with leading academic institutions to advance the knowledge and practice of kidney care for dialysis patients.

The abstracts featured include:

-- Association of Low Body Mass Index (BMI) and Weight Loss with Increased Mortality in Transplant-Wait-Listed Maintenance Hemodialysis Patients

Kamyar Kalantar-Zadeh, MD PhD; Elani Streja, MPH; Jennie Jing, MS; Csaba P. Kovesdy, MD; David Van Wyck, MD; Gabriel M. Danovitch, MD; and Suphamai Bunnapradist, MD.

-- Association Between Laboratory Surrogates of Renal Osteodystrophy and ESA Responsiveness in Maintenance Hemodialysis Patients

Kamyar Kalantar-Zadeh, MD PhD; Deborah L. Regidor, PhD; Jennie Jing, MS; David Van Wyck, MD; and Csaba P. Kovesdy, MD.

-- Survival Benefit Associated with Cinacalet Use in a Large Cohort of Hemodialysis patients with Secondary Hyperparathyroidism

Geoffrey Block, MD; Gerard Smits, PhD; Martha Persky, RN; Stephanie Brillhart; Jiannong Liu; and Wendy St-Peter.

-- Risk Factors Associated with Sudden Cardiac Arrest in Hemodialysis Patients: A Case-Control Study

Patrick H Pun, MD; Ruediger Lehrich, MD; Emily Honeycutt, MS; Linda Shaw, MS; and John P Middleton, MD.

-- Catheter Removal is Associated with Improved Serum Albumin Levels in Maintenance Hemodialysis Patients

Debbie Benner, MA RD CSR; Ram Dukkipati, MD; Joe Weldon, MBA; David Van Wyck, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Mortality Predictability of the 5-Year Time-Averaged Serum Calcium in 151,555 Maintenance Hemodialysis Patients

Jessica E. Miller, MPH; Csaba P. Kovesdy, MD; David Van Wyck, MD; Joel D. Kopple, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Greater Fluid Retention is Associated with Higher Mortality in Maintenance Hemodialysis Patients

Deborah L. Regidor, PhD; Csaba P. Kovesdy, MD; Suphamai Bunnapradist, MD; David Van Wyck, MD; Tamara B. Horwich, MD; Gregg C. Fonarow, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Independent Association of Hemodialysis Treatment Session Time and 5-Year Survival in 88,153 Maintenance Hemodialysis Patients

Jessica E. Miller, MPH; Csaba P. Kovesdy, MD; Jennie Jing, MS; David Van Wyck, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Association between Time-Averaged (Cumulative) Hemodialysis Dose and 5-year Survival CKD Patients

Jessica E. Miller, MPH; Elani Streja, MPH; Csaba P. Kovesdy, MD; David Van Wyck, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Higher Body mass Index (BMI) at the Time of Transplantation is Associated with Greater 5.Year Patient and Graft Survival in 8,529 Renal Transplant Recipients

Elani Streja, MPH; Suphamai Bunnapradist, MD; Csaba P. Kovesdy, MD; Gabriel M. Danovitch, MD; David Van Wyck, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Association of Low Serum Calcium with ESA Hypo-Responsiveness in Hemodialysis Patients

Deborah L. Regidor, PhD; Jennie Jing, MS; David Van Wyck, MD; Csaba P. Kovesdy, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Can Better Nutritional Status Explain Greater Survival of Hispanic Hemodialysis Patients?

Elani Streja, MPH; Stephen F. Derose, MD MPH; Steven J. Jacobsen, MD PhD; Scott Rasgon, MD; Csaba P. Kovesdy, MD; David Van Wyck, MD; and Kamyar Kalantar-Zadeh, MD PhD.

-- Managing the Complexities of CKD Mineral and Bone Disorders: A Unique Tool

Debbie Benner, MA RD CSR; Mary Burgess, RD; Allen Nissenson, MD; and David Van Wyck, MD.

-- Clinical Performance in a Large Dialysis organization: Effect of Length of Facility Ownership

David Van Wyck, MD; John Robertson, MD; Allen Nissenson, MD; Robert Provenzano, MD; and Dennis Kogod.

-- Erythrocyte Membrane fatty acid composition in ESRD patients

Charles Kert, MD; Peter Klementowicz, MD; Joyce Clouser, RD; and William S. Harris, PhD.

DCR, through its commitment to quality, timely and accurate clinical trials, plays a valuable role by partnering with physicians, pharmaceutical and biotechnology companies to develop and progress new drug therapies for patients diagnosed with CKD.

DaVita and DaVita Clinical Research are registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,400 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 110,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials, and its community programs, please visit http://www.davita.com.


'/>"/>
SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DaVita Receives Civil Complaint
2. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
3. DaVita Teammates Bicycling 230 Miles for Kidney Disease Education
4. DaVita Volunteers Raise More than $1,000,000 for Nationwide Kidney Education and Prevention Programs
5. DaVita Emergency Response Efforts Ensure Vital Treatment for More than 700 Kidney Failure Patients in Need of Life-Saving Dialysis Treatments in Areas Affected by Southern California Wildfires
6. DaVita to Open First Independent Dialysis Clinic in Fargo-Moorhead
7. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
8. DaVita Inc. to Present at JPMorgan Healthcare Conference
9. DaVita and Phoenix-Based Southwest Kidney Institute Form Broad Partnership
10. Nations Leading Dialysis Provider - DaVita - Partners with eDiets(R) to Launch One-of-a-Kind Diet Helper Online Nutrition and Meal Planning Tool for Late-Stage Kidney Disease Patients and Caregivers
11. DaVita Announces Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: